Cerebroprotective Effect against Cerebral Ischemia of the Combined Extract of <i>Oryza sativa</i> and <i>Anethum graveolens</i> in Metabolic Syndrome Rats

<div>Schematic diagram showing all experimental procedures. (a) Experimental protocol of OA extract treatment and the determination of various parameters. (b) Right MCAO induction and schedule for OA extract treatment. IL-6: interleukin-6; NF-<i>κ</i>B: nuclear factor-kappaB; HCHF: high-carbohydrate high-fat diet; MCAO: right middle cerebral artery occlusion; OA1, OA2, and OA3: the combined extract of <i>O. sativa</i> and <i>A. graveolens</i> at doses of 0.5, 5, and 50 mg/kg BW, respectively.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Cerebroprotective Effect against Cerebral Ischemia of the Combined Extract of <i>Oryza sativa</i> and <i>Anethum graveolens</i> in Metabolic Syndrome Rats 

Figure 1 | Cerebroprotective Effect against Cerebral Ischemia of the Combined Extract of Oryza sativa and Anethum graveolens in Metabolic Syndrome Rats 